Cullinan Therapeutics, Inc. CGEM Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s operating lease liabilities (total)?
- Cullinan Therapeutics, Inc. (CGEM) reported operating lease liabilities (total) of $2.38M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Cullinan Therapeutics, Inc.'s operating lease liabilities (total) increased by 29.5% year-over-year, from $1.84M to $2.38M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 3 years (2022 to 2025), Cullinan Therapeutics, Inc.'s operating lease liabilities (total) has grown at a -18.8% compound annual growth rate (CAGR), from $5.01M to $2.68M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.